2480 — Beijing Luzhu Biotechnology Co Cashflow Statement
0.000.00%
Last trade - 00:00- HK$4.90bn
- HK$4.27bn
Annual cashflow statement for Beijing Luzhu Biotechnology Co, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | ARS |
| Standards: | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final |
| Net Income/Starting Line | -539 | -725 | -249 |
| Depreciation | |||
| Amortisation | |||
| Non-Cash Items | 512 | 640 | 45 |
| Unusual Items | |||
| Other Non-Cash Items | |||
| Changes in Working Capital | 1.98 | -1.82 | -1.72 |
| Change in Inventories | |||
| Change in Prepaid Expenses | |||
| Change in Other Liabilities | |||
| Cash from Operating Activities | -19.2 | -77.3 | -190 |
| Capital Expenditures | -78.5 | -257 | -87.1 |
| Purchase of Fixed Assets | |||
| Purchase / Acquisition of Intangibles | |||
| Other Investing Cash Flow Items | -325 | 33.8 | 186 |
| Sale of Fixed Assets | |||
| Sale/Maturity of Investment | |||
| Purchase of Investments | |||
| Other Investing Cash Flow | |||
| Cash from Investing Activities | -404 | -223 | 98.6 |
| Financing Cash Flow Items | 443 | 329 | -34 |
| Other Financing Cash Flow | |||
| Net Issuance / Retirement of Stock | |||
| Net Issuance / Retirement of Debt | |||
| Cash from Financing Activities | 455 | 337 | 273 |
| Foreign Exchange Effects | |||
| Beginning Cash Balance | |||
| Ending Cash Balance | |||
| Net Change in Cash | 31.8 | 36.9 | 189 |